Continuing issues and debate concerning transnational commercial surrogacy during the COVID-19 pandemic and beyond
By Yuri Hibino, Sonia Allan, and Damian Adams,
BioNews
| 11. 30. 2020
The regulation of surrogacy varies around the world. Most countries that have laws, prohibit all forms of surrogacy, while several permit altruistic arrangements. A small number permit commercial surrogacy arrangements, and accept commissioning couples, or singles from nations where prohibitions exist. As a result, issues abound. For example, despite growing recognition that children have a right to information about their birth mother, gamete donor(s), and genetic siblings, transnational arrangements may provide little to no opportunity to build relationships when separated by language, culture, and/or location. Issues regarding the sale and commodification of children persist; cases of child abandonment are known. Trafficking of women across borders, bonded labour, health risks associated with surrogacy and egg donation, and ill-treatment of surrogates and intending mothers reported.
In 2020, COVID-19 also saw up to 1000 babies left in hospitals (or orphanages) in Russia, with intending parents unable to travel. In the Ukraine, babies were cared for in hotel rooms by nurses or nannies, or placed into public care (see BioNews 1048). Some surrogates struggled as they bonded with the baby or worried... see more
Related Articles
By Catherine Hsu, The Daily Californian | 04.01.2021
CRISPR genome editing technology, which was developed at UC Berkeley, has been approved for clinical trials to correct gene mutations responsible for sickle cell disease.
Sickle cell disease has been an “early target” for gene therapy because it is caused...
By Rob Stein, NPR | 03.17.2021
For decades, science has been trying to unlock the mysteries of how a single cell becomes a fully formed human being and what goes wrong to cause genetic diseases, miscarriages and infertility.
Now, scientists have created living entities in their...
At least five separate studies involving human embryo research are raising fresh versions of old questions about science, ethics and regulation. On March 17, Nature published two peer-reviewed papers about generating in vitro, with slightly different methods, “blastoids” or “human blastocyst-like structures.” (One team, perhaps trying to be cute, called them “iBlastoids” but the Nature summary article sensibly eschews this.) One process involved developing from human embryonic stem cells, the other used cells reprogrammed from adult tissues. A few...
By Ian Sample, The Guardian | 03.11.2021
Photo by Sharon McCutcheon on Unsplash
Twins may be more common today than at any time in history, according to the first comprehensive survey of twin births around the world.
Researchers analysed records from more than 100 countries and found...
